REFERENCES
- Agami R, Bernards R. 2000. Distinct initiation and maintenance mechanisms cooperate to induce G1 cell cycle arrest in response to DNA damage. Cell 102:55–66.
- Alt JR, Cleveland JL, Hannink M, Diehl JA. 2000. Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation. Genes Dev. 14:3102–3114.
- Ang XL, Wade Harper J. 2005. SCF-mediated protein degradation and cell cycle control. Oncogene 24:2860–2870.
- Baldin V, Lukas J, Marcote MJ, Pagano M, Draetta G. 1993. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev. 7:812–821.
- Barbash O, et al. 2008. Mutations in Fbx4 inhibit dimerization of the SCFFbx4 ligase and contribute to cyclin D1 overexpression in human cancer. Cancer Cell 14:68–78.
- Bessho Y, et al. 2001. Dynamic expression and essential functions of Hes7 in somite segmentation. Genes Dev. 15:2642–2647.
- Blain SW. 2008. Switching cyclin D-Cdk4 kinase activity on and off. Cell Cycle 7:892–898.
- Buckley MF, et al. 1993. Expression and amplification of cyclin genes in human breast cancer. Oncogene 8:2127–2133.
- Diehl JA, Cheng M, Roussel MF, Sherr CJ. 1998. Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 12:3499–3511.
- Diehl JA, Zindy F, Sherr CJ. 1997. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev. 11:957–972.
- Fukami-Kobayashi J, Mitsui Y. 1999. Cyclin D1 inhibits cell proliferation through binding to PCNA and cdk2. Exp. Cell Res. 246:338–347.
- Guo Y, et al. 2005. Phosphorylation of cyclin D1 at Thr 286 during S phase leads to its proteasomal degradation and allows efficient DNA synthesis. Oncogene 24:2599–2612.
- Ishida N, et al. 2002. Phosphorylation of p27Kip1 on serine 10 is required for its binding to CRM1 and nuclear export. J. Biol. Chem. 277:14355–14358.
- Kamura T, et al. 2004. Cytoplasmic ubiquitin ligase KPC regulates proteolysis of p27Kip1 at G1 phase. Nat. Cell Biol. 6:1229–1235.
- Kim JK, Diehl JA. 2009. Nuclear cyclin D1: an oncogenic driver in human cancer. J. Cell. Physiol. 220:292–296.
- Kozar K, et al. 2004. Mouse development and cell proliferation in the absence of D-cyclins. Cell 118:477–491.
- Lee TH, Perrem K, Harper JW, Lu KP, Zhou XZ. 2006. The F-box protein FBX4 targets PIN2/TRF1 for ubiquitin-mediated degradation and regulates telomere maintenance. J. Biol. Chem. 281:759–768.
- Lin DI, et al. 2006. Phosphorylation-dependent ubiquitination of cyclin D1 by the SCFFBX4-αB crystallin complex. Mol. Cell 24:355–366.
- Malumbres M, et al. 2004. Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6. Cell 118:493–504.
- Matsushime H, et al. 1992. Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins. Cell 71:323–334.
- Matsushime H, et al. 1994. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14:2066–2076.
- Matsushime H, Roussel MF, Ashmun RA, Sherr CJ. 1991. Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 65:701–713.
- Meyerson M, Harlow E. 1994. Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell. Biol. 14:2077–2086.
- Motokura T, et al. 1991. A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature 350:512–515.
- Nakayama K, et al. 1996. Mice lacking p27Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85:707–720.
- Nakayama K, et al. 2000. Targeted disruption of Skp2 results in accumulation of cyclin E and p27Kip1, polyploidy and centrosome overduplication. EMBO J. 19:2069–2081.
- Nakayama K, et al. 2004. Skp2-mediated degradation of p27 regulates progression into mitosis. Dev. Cell 6:661–672.
- Nakayama KI, Nakayama K. 2006. Ubiquitin ligases: cell-cycle control and cancer. Nat. Rev. Cancer 6:369–381.
- Newman RM, et al. 2004. Antizyme targets cyclin D1 for degradation. A novel mechanism for cell growth repression. J. Biol. Chem. 279:41504–41511.
- Okabe H, et al. 2006. A critical role for FBXW8 and MAPK in cyclin D1 degradation and cancer cell proliferation. PLoS One 1:e128.
- Pagano M, Theodoras AM, Tam SW, Draetta GF. 1994. Cyclin D1-mediated inhibition of repair and replicative DNA synthesis in human fibroblasts. Genes Dev. 8:1627–1639.
- Pawar SA, et al. 2010. C/EBPδ targets cyclin D1 for proteasome-mediated degradation via induction of CDC27/APC3 expression. Proc. Natl. Acad. Sci. U. S. A. 107:9210–9215.
- Pontano LL, et al. 2008. Genotoxic stress-induced cyclin D1 phosphorylation and proteolysis are required for genomic stability. Mol. Cell. Biol. 28:7245–7258.
- Rappsilber J, Ishihama Y, Mann M. 2003. Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics. Anal. Chem. 75:663–670.
- Santra MK, Wajapeyee N, Green MR. 2009. F-box protein FBXO31 mediates cyclin D1 degradation to induce G1 arrest after DNA damage. Nature 459:722–725.
- Shinozaki H, et al. 1996. Cyclin D1 amplification as a new predictive classification for squamous cell carcinoma of the esophagus, adding gene information. Clin. Cancer Res. 2:1155–1161.
- Sicinski P, et al. 1995. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82:621–630.
- Solomon DA, et al. 2003. Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation. J. Biol. Chem. 278:30339–30347.
- Tsunematsu R, et al. 2006. Fbxw8 is essential for Cul1-Cul7 complex formation and for placental development. Mol. Cell. Biol. 26:6157–6169.
- Wang TC, et al. 1994. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369:669–671.
- Wei S, et al. 2008. A novel mechanism by which thiazolidinediones facilitate the proteasomal degradation of cyclin D1 in cancer cells. J. Biol. Chem. 283:26759–26770.
- Xu X, et al. 2008. The CUL7 E3 ubiquitin ligase targets insulin receptor substrate 1 for ubiquitin-dependent degradation. Mol. Cell 30:403–414.
- Yang WI, Zukerberg LR, Motokura T, Arnold A, Harris NL. 1994. Cyclin D1 (Bcl-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia. Am. J. Pathol. 145:86–96.
- Yu ZK, Gervais JL, Zhang H. 1998. Human CUL-1 associates with the SKP1/SKP2 complex and regulates p21CIP1/WAF1 and cyclin D proteins. Proc. Natl. Acad. Sci. U. S. A. 95:11324–11329.